Studies from National Health Insurance Service Ilsan Hospital in the Area of Acinetobacter baumannii Published (Antimicrobial Resistance Patterns of Acinetobacter baumannii and Pseudomonas aeruginosa Isolated From Vulnerable Patients in Korea, …): Gram-Negative Bacteria – Acinetobacter baumannii

2023 JUN 16 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- Researchers detail new data in Acinetobacter baumannii. According to news originating from Goyang, South Korea, by NewsRx correspondents, research stated, “We compared the antimicrobial resistance rates (AMRs) of major glucose non-fermenting gram-negative bacilli, Acinetobacter baumannii and Pseudomonas aeruginosa, under different clinical conditions.”

Our news reporters obtained a quote from the research from National Health Insurance Service Ilsan Hospital: “The purpose of the study was to provide useful background data to set up infection control strategies for infection-vulnerable patients. The AMRs of blood isolates were compared in various clinical conditions, using data from the Antimicrobial Resistance Surveillance System in Korea. A. baumannii blood isolates from patients with healthcare-associated infections, inpatients, or intensive care unit (ICU)-admitted patients consistently exhibited higher AMRs to most antimicrobials, except minocycline, tigecycline, and colistin, compared with those from patients with community-acquired infections, outpatients, or non-ICU-admitted patients, respectively. P. aeruginosa blood isolates from patients with healthcare-associated infections showed higher AMRs to most antimicrobials, except ceftazidime and aztreonam, compared with those from patients with community-acquired infections, but not compared to those from inpatients or ICU-admitted patients.”

According to the news editors, the research concluded: “Higher AMRs were associated with A. baumannii bloodstream infections under various clinical conditions, such as healthcare-associated infections and infections in inpatients and ICU-admitted patients. Considering the high AMRs and the limited number of treatment options of A. baumannii, vigorous efforts should be used to prevent the spreading of A. baumannii infections in patients with vulnerable conditions.”

For more information on this research see: Antimicrobial Resistance Patterns of Acinetobacter baumannii and Pseudomonas aeruginosa Isolated From Vulnerable Patients in Korea, 2021. Annals of Clinical Microbiology, 2022,25(4):145-153. The publisher for Annals of Clinical Microbiology is Korean Society of Clinical Microbiology.

A free version of this journal article is available at https://doi.org/10.5145/ACM.2022.25.4.4.

Our news journalists report that more information may be obtained by contacting Young Ah Kim, Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, South Korea. Additional authors for this research include Seok Hoon Jeong, Jong Hee Shin, Kyeong Seob Shin, Jeong Hwan Shin, Young Ree Kim, Hyun Soo Ki, Young Uh, Nam Hee Ryoo. Our reports deliver fact-based news of research and discoveries from around the world.